Abstract Details

Title Interim Analysis of the Effectiveness of Second-Line Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients Treated with Prior First-Line Treatment, Other Than Natalizumab, in Spain: The Observational, Retrospective NEXT Study

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 106

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Virginia Meca Lallana PRESENTER	Virginia Meca Lallana has nothing to disclose.
	No disclosure on file
Javier Jose Mallada (Hospital Elda)	No disclosure on file
Eugenia Marzo	No disclosure on file
Francisco Barrero	No disclosure on file
Francisco Javier Ricart	Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��